ATE210449T1 - Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards - Google Patents

Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards

Info

Publication number
ATE210449T1
ATE210449T1 AT92912078T AT92912078T ATE210449T1 AT E210449 T1 ATE210449 T1 AT E210449T1 AT 92912078 T AT92912078 T AT 92912078T AT 92912078 T AT92912078 T AT 92912078T AT E210449 T1 ATE210449 T1 AT E210449T1
Authority
AT
Austria
Prior art keywords
composition
myocardial reperfusion
reperfusion damage
reducing myocardial
adenosine
Prior art date
Application number
AT92912078T
Other languages
English (en)
Inventor
Mervyn B Forman
Edwin K Jackson
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Application granted granted Critical
Publication of ATE210449T1 publication Critical patent/ATE210449T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
AT92912078T 1991-05-22 1992-03-26 Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards ATE210449T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/704,058 US5206222A (en) 1991-05-22 1991-05-22 Methods for the reduction of myocardial reperfusion injury
PCT/US1992/002528 WO1992020346A1 (en) 1991-05-22 1992-03-26 Method and composition to reduce myocardial reperfusion injury

Publications (1)

Publication Number Publication Date
ATE210449T1 true ATE210449T1 (de) 2001-12-15

Family

ID=24827883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912078T ATE210449T1 (de) 1991-05-22 1992-03-26 Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards

Country Status (7)

Country Link
US (1) US5206222A (de)
EP (1) EP0589964B1 (de)
JP (1) JPH06510751A (de)
AT (1) ATE210449T1 (de)
CA (1) CA2103458C (de)
DE (1) DE69232287T2 (de)
WO (1) WO1992020346A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
AU4888397A (en) * 1997-09-22 1999-04-12 Item Development Ab New method of treatment
WO1999017784A1 (en) * 1997-10-07 1999-04-15 Regents Of The University Of California Corporation Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine
US6015384A (en) * 1998-08-31 2000-01-18 Acuson Corporation Ultrasonic system and method for tissue viability imaging
EP2359688B1 (de) 1999-03-23 2015-05-27 Hibernation Therapeutics, a KF LLC Organstillstand, -schutz und -erhaltung
US6368573B1 (en) * 1999-11-15 2002-04-09 King Pharmaceuticals Research And Development, Inc. Diagnostic uses of 2-substituted adenosine carboxamides
US6599283B1 (en) * 2001-05-04 2003-07-29 Cv Therapeutics, Inc. Method of preventing reperfusion injury
DE10258770B4 (de) * 2001-12-18 2005-02-10 F. Hoffmann-La Roche Ag Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen
AUPS312602A0 (en) * 2002-06-21 2002-07-18 James Cook University Organ arrest, protection, preservation and recovery
US20060034941A1 (en) * 2002-12-23 2006-02-16 Global Cardiac Solutions Pty Ltd Organ preconditioning, arrest, protection, preservation and recovery
AU2003291847B2 (en) * 2002-12-23 2010-12-02 Hibernation Therapeutics, A Kf Llc Organ preconditioning, arrest, protection, preservation and recovery
AU2005249430B2 (en) * 2004-05-26 2011-06-23 Inotek Pharmaceuticals Corporation Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
US20110076255A1 (en) * 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
AU2006320578B2 (en) * 2005-11-30 2013-01-31 Inotek Pharmaceuticals Corporation Purine derivatives and methods of use thereof
JP2009538834A (ja) * 2006-05-29 2009-11-12 ハイバーネイション セラピューティクス リミテッド 組織維持の改善
CA2692256C (en) 2006-07-25 2017-01-10 Hibernation Therapeutics Limited Trauma therapy
CA2717162A1 (en) 2007-03-02 2008-09-12 Hibernation Therapeutics Limited Transplants
US20080269109A1 (en) * 2007-04-30 2008-10-30 Becker Lance B System and method of resuscitation of a mammal
US20090136460A1 (en) * 2007-07-10 2009-05-28 Vanderbilt University Use of adenosine receptor ligands to promote cell adhesion in cell-based therapies
WO2009012534A1 (en) * 2007-07-25 2009-01-29 Hibernation Therapeutics Limited Improved organ protection, preservation and recovery
US20090218349A1 (en) * 2008-02-29 2009-09-03 Silgan Containers Corporation Vacuum container with protective features
ME02608B (de) 2010-01-11 2017-06-20 Inotek Pharmaceuticals Corp Kombination, kit und verfahren zur reduzierung des augeninnendrucks
CN102933593A (zh) 2010-03-26 2013-02-13 伊诺泰克制药公司 使用n6-环戊基腺苷（cpa）、cpa衍生物或其前药降低人眼内压的方法
US9278991B2 (en) 2012-01-26 2016-03-08 Inotek Pharmaceuticals Corporation Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
BR112015021870A2 (pt) 2013-03-15 2017-07-18 Inotek Pharmaceuticals Corp formulações oftálmicas
BR112016000804A2 (pt) 2013-07-17 2017-08-22 Hibernation Therapeuitics A Kf Llc Método para tratar hemorragia, choque e lesão cerebral

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
AU612331B2 (en) * 1986-09-30 1991-07-11 Ciba-Geigy Ag 2-substituted-e-fused-(1,2,4)triazolo(1,5-c)pyrimidines pharmaceutical compositions
IL84414A0 (en) * 1986-11-14 1988-04-29 Ciba Geigy Ag N9-cyclopentyl-substituted adenine derivatives
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
AU3820989A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives
JPH0725785B2 (ja) * 1989-01-11 1995-03-22 日本臓器製薬株式会社 アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物

Also Published As

Publication number Publication date
WO1992020346A1 (en) 1992-11-26
DE69232287T2 (de) 2002-07-25
CA2103458A1 (en) 1992-11-23
CA2103458C (en) 2000-11-14
JPH06510751A (ja) 1994-12-01
DE69232287D1 (de) 2002-01-24
EP0589964A4 (en) 1994-05-25
EP0589964A1 (de) 1994-04-06
EP0589964B1 (de) 2001-12-12
US5206222A (en) 1993-04-27

Similar Documents

Publication Publication Date Title
ATE210449T1 (de) Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards
ATE188341T1 (de) Konservierungsmittel und verfahren zur behandlung von holz
DE3674308D1 (de) Biozide zusammensetzungund verfahren zur behandlung von wasser.
RU93048466A (ru) Применение бензотиофенов для профилактики и лечения остеопороза и фармацевтическая композиция на их основе
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
BR9304988A (pt) Composições auto-dispersáveis em água contendo organopolissiloxano e processo para o tratamento de madeira
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
ATE133564T1 (de) Flupirtin in kombination mit antiparkinsonika zur bekämpfung von muskelverspannungen
MX9300603A (es) Derivados tiaciclicos de piperidinilo.
ATE190840T1 (de) Zusammensetzung zur behandlung der parkinson- krankheit
FI831230A0 (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
DE3576834D1 (de) Oberflaechlich behandeltes magnesium oder dessen legierungen und verfahren zum oberflaechenbehandeln.
DE3650620D1 (de) Behandlungsverfahren kataboler dysfunktion
DE60133887D1 (de) Adenosin a2a rezeptor-antagonisten zur behandlung und vorbeugung von leberfibrose, zirrhose und fettleber
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
EP1037918A4 (de) Verfahren und zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
DE69314022D1 (de) Derivate von 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranen
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
FI900372A7 (fi) Aryyli- ja heteroaryylietanoli-pyridyylialkyyliamiinit, menetelmä niiden valmistamiseksi ja niiden käyttö suoritusta edistävinä aineina eläimillä ja liikalihavuuden hoitoon käytettävinä aineina
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee